C-550-01

A Phase 1 / 2, Open-Label, Multi-Arm Trial to Investigate the Safety, Tolerability,
Pharmacokinetics, Biological, and Clinical Activity of AGEN1884 in Combination
with AGEN2034 in Subjects with Metastatic or Locally Advanced Solid Tumors, and
Expansion into Select Solid Tumors